🔗 Permalink

Inventor profile of:

Li Ren

City:

Boulder, Colorado

Country:

United States

Published Applications:

Last publication date:

2024-02-29

Top Assignees for applications by Li Ren

The entities that hold a legal rights for patent applications filed by inventor Ren Li:

ARRAY BIOPHARMA INC. 30 Boulder, CO United States
Genentech, Inc. 13 South San Francisco, CA United States
Array BioPharma Inc. 2 Indianapolis, IN United States
Genetech, Inc. 1 South San Francisco, CA United States
Array BioPharma Inc. 1 Boulder, United States
Array Bio Pharma Inc. 1 Boulder, CO United States
Grenentech ,Inc. 1 South San Francisco, CA United States
Array BioPharma Inc. 1 Boudler, CO United States
ELI LILLY AND COMPANY 1 Indianapolis, IN United States

Recent patent applications by Ren Li

Li Ren from Boulder, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-02-29

US20240066029A1

Human necessities

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

#2 | 2023-03-23

US20230090520A1

Human necessities

SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS

#3 | 2022-10-06

US20220313676A1

Human necessities

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#4 | 2022-04-21

US20220119396A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors

#5 | 2022-03-17

US20220081438A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kinases

#6 | 2021-06-24

US20210186959A1

Human necessities

SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS

#7 | 2020-12-24

US20200399279A1

Chemistry; metallurgy

Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors

#8 | 2020-12-10

US20200383966A9

Human necessities

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#9 | 2020-10-29

US20200339589A1

Chemistry; metallurgy

Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors

#10 | 2020-10-29

US20200339579A1

Chemistry; metallurgy

Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors

#11 | 2020-02-20

US20200055860A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors

#12 | 2020-01-30

US20200030311A1

Human necessities

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#13 | 2019-10-03

US20190300511A1

Chemistry; metallurgy

2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

#14 | 2019-06-20

US20190183886A1

Human necessities

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#15 | 2018-05-31

US20180148445A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#16 | 2018-05-17

US20180134703A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#17 | 2018-05-17

US20180134702A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#18 | 2018-05-17

US20180133213A1

Human necessities

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#19 | 2018-05-17

US20180133207A1

Human necessities

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

#20 | 2018-05-17

US20180133200A1

Human necessities

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

#21 | 2018-05-10

US20180127393A1

Chemistry; metallurgy

Serine/threonine kinase inhibitors

#22 | 2017-12-07

US20170348310A1

Human necessities

Serine/threonine kinase inhibitors

#23 | 2017-09-14

US20170260168A1

Chemistry; metallurgy

2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

#24 | 2016-10-20

US20160304519A1

Chemistry; metallurgy

Serine/threonine kinase inhibitors

#25 | 2016-10-20

US20160303126A1

Human necessities

Serine/threonine kinase inhibitors

#26 | 2016-05-05

US20160122316A1

Chemistry; metallurgy

Serine/threonine kinase inhibitors

#27 | 2014-09-04

US20140249127A1

Chemistry; metallurgy

Serine/threonine kinase inhibitors

#28 | 2014-08-14

US20140228349A1

Chemistry; metallurgy

5,7-SUBSTITUTED-IMIDAZO[1,2-C]PYRIMIDINES

#29 | 2013-12-19

US20130338140A1

Chemistry; metallurgy

Serine/threonine kinase inhibitors

#30 | 2013-09-26

US20130252934A1

Human necessities

Serine/threonine kinase inhibitors

#31 | 2013-01-17

US20130018033A1

Chemistry; metallurgy

RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF

#32 | 2012-06-21

US20120157452A1

Chemistry; metallurgy

1H-PYRAZOLO[3,4-B] PYRIDINE COMPOUNDS FOR INHIBITING RAF KINASE

#33 | 2012-06-21

US20120157451A1

Chemistry; metallurgy

RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF

#34 | 2012-06-21

US20120157439A1

Chemistry; metallurgy

RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF

#35 | 2011-05-12

US20110110889A1

Chemistry; metallurgy

Raf inhibitor compounds and methods of use thereof

#36 | 2011-04-21

US20110092479A1

Chemistry; metallurgy

Pyrazole [3, 4-B] pyridine Raf inhibitors

#37 | 2010-03-11

US20100063066A1

Chemistry; metallurgy

RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF

InventorID:

42389 ⎘